Analyst Ratings for BridgeBio Pharma (BBIO)

BBIO Rating Summary

BBIO Price Target Summary

* Over Last 12-Mos
  |   Expand Research on BBIO
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $81.50 (+51.9%) * Over Last 12-Mos
Rating Score: 9.1 / 10   Percentile Rank: 89%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/22/2021 JPMorgan Anupam Rama New Coverage Overweight
(N/A)
78.00
(N/A)
63.85
(53.66)
-15.96% Details
2/9/2021 Goldman Sachs
» Updated 5/10/2021
Paul Choi New Coverage Buy
(N/A)
80.00
(92.00)
68.28
(53.66)
-21.41% Details
Like BBIO Ratings? Also take a look at EIDX, PRTA, ON, PEGA

BBIO Ratings News